Biomelab S.A.S.
Barranquilla, Atlántico
- UEI
- UM9NYWJF4PB6
- CAGE
- A0UCZ
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- Cra. 59 #72-115, La Concepción, Barranquilla, Atlántico, Colombia
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Children's Research Institute | R01HD102445 | $136,384 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Instituto Conmemorativo Gorgas De Estudios De La Salud | Panama City, Panamá Province | 621511 Medical Laboratories |
| Fundacao De Apoio AO Ensino A Pesquisa E A Extensao De Servicos A Comunidade DA Faculdade De Medicina De SAO Jose Do RIO Preto - Faepe | SP | 611710 Educational Support Services |
| SSI | Oakland, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Fsig | Ciudad de Guatemala, Guatemala | 541990 All Other Professional, Scientific, and Technical Services |
| Infinity Bio, Inc. | Baltimore, MD | 541380 Testing Laboratories and Services |
About the company
Biomelab S.A.S., a Colombian-based for-profit organization registered in SAM.gov since September 2010, is a research-focused entity located in Barranquilla, Atlántico. The company is structured as a partnership or limited liability partnership and has established itself as a participant in federal grant sub-award programs. While specific details about the company's primary business operations are not fully disclosed in the provided documentation, the organization appears to be involved in medical and scientific research, particularly in the field of epidemiology and pediatric health studies.
The company has consistently been involved in federal grant sub-awards related to pediatric health research, specifically focusing on childhood outcomes following Zika virus (ZIKV) exposure. Biomelab S.A.S. has received multiple sub-grant awards from the Children's Research Institute, with recent awards dated January 29, 2025, January 18, 2022, and May 25, 2021. These grant awards consistently center on the research project "Childhood Outcome After In Utero ZIKV Exposure," suggesting a specialized focus on understanding the long-term health implications of Zika virus infection during pregnancy. The recurring nature of these grants indicates that Biomelab S.A.S. has developed expertise in this specific area of pediatric and epidemiological research, potentially contributing valuable scientific insights to understanding the impacts of viral exposure on child development.
Quick answers
Is Biomelab S.A.S. registered in SAM.gov?
Yes. Biomelab S.A.S.'s SAM.gov registration is active through February 6, 2027.
On GovTribe
See Biomelab S.A.S.'s full federal record
- Similar vendors